Xiaobo Guo
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 6
- RNA Research and Splicing 4
- Kruppel-like factors research 3
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 10
- Co-authors
- Leping Li (18 shared papers)Qiaoming Zhi (16 shared papers)Yulong Shi (7 shared papers)Changqing Jing (10 shared papers)Xiaofeng Xue (9 shared papers)Jinshen Wang (9 shared papers)Chensheng Li (5 shared papers)Pu Li (4 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)World Journal of Gastroenterology (3 papers)Anti-Cancer Agents in Medicinal Chemistry (3 papers)BMC Cardiovascular Disorders (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaobo Guo
66 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 505
- Molecular Biology 722
- Oncology 158
- Hepatology 31
- Animal Science and Zoology 39
Countries citing papers authored by Xiaobo Guo
This map shows the geographic impact of Xiaobo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Guo more than expected).
Fields of papers citing papers by Xiaobo Guo
This network shows the impact of papers produced by Xiaobo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Guo. The network helps show where Xiaobo Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobo Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 93 | |
| 2 | 2013 | 89 | |
| 3 | 2011 | 62 | |
| 4 | 2015 | 55 | |
| 5 | 2016 | 46 | |
| 6 | 2021 | 44 | |
| 7 | 2013 | 40 | |
| 8 | Biological significance of long non-coding RNA FTX expression in human colorectal cancer. | 2015 | 38 |
| 9 | 2010 | 37 | |
| 10 | 2014 | 35 | |
| 11 | 2013 | 35 | |
| 12 | 2014 | 34 | |
| 13 | 2014 | 34 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 32 | |
| 16 | 2013 | 29 | |
| 17 | 2015 | 27 | |
| 18 | 2015 | 26 | |
| 19 | 2018 | 26 | |
| 20 | 2020 | 25 |
About Xiaobo Guo
Xiaobo Guo is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 70 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (8 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (4 papers), Kruppel-like factors research (3 papers), Cancer Cells and Metastasis (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). The work is most often cited by research in Cancer Research (505 citations), Molecular Biology (722 citations), Oncology (158 citations), Hepatology (31 citations) and Animal Science and Zoology (39 citations). Xiaobo Guo has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Leping Li, Qiaoming Zhi, Yulong Shi, Changqing Jing, Xiaofeng Xue, Jinshen Wang, Chensheng Li, Pu Li, Jinglei Liu and Ye Han. Their work appears in journals such as Biomedicine & Pharmacotherapy, World Journal of Gastroenterology, Anti-Cancer Agents in Medicinal Chemistry, BMC Cardiovascular Disorders and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.